Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
None
Hematopoietic Stem Cell Therapy for Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy

The purpose of this study is to assess the efficacy of autologous PBSCT versus FDA approved standard of care (i.e. interferon, glatiramer acetate, mitoxantrone, natalizumab, fingolimod, or tecfidera) for inflammatory MS failing alternate approved therapy. Disease progression, defined as a 1-point increase in the Expanded Disability Status scale (EDSS) on …

MRI
fingolimod
corticosteroids
tysabri
betaseron
  • 120 views
  • 08 Nov, 2020
  • 1 location
None
Examining Effects of Tysabri on Cognitive Fatigue Using fMRI

The purpose of this research study is to investigate the effectiveness of Tysabri on cognitive fatigue in persons with Relapsing-Remitting Multiple Sclerosis (RRMS). Cognitive fatigue is the

  • 0 views
  • 07 Aug, 2021
  • 1 location
None
Biogen Multiple Sclerosis Pregnancy Exposure Registry

The primary objective of the study is to prospectively evaluate pregnancy outcomes in women with multiple sclerosis who were exposed to a Registry-specified Biogen Multiple Sclerosis product during the eligibility window for that product. The Registry-specified Biogen MS products being studied are dimethyl fumarate, and Pegylated human interferon beta-1a. The …

disease or disorder
dimethyl fumarate
interferon
  • 92 views
  • 02 Nov, 2021
  • 19 locations
None
Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants

The purpose of this study is to evaluate the impact of an early treatment with Natalizumab on the management of the progressive nature of Relapsing Remitting Multiple Sclerosis (RRMS).

  • 0 views
  • 12 Apr, 2021
  • 18 locations
None
Comparing the Safety and Benefit of Natalizumab (Tysabri ) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis

At-home use of Natalizumab in multiple sclerosis (MS) patients has been temporarily granted by French security agency of medicines and Health products (ANSM). The main objective of the study is to compare the safety of natalizumab administration at home vs at hospital based on retrospective and prospective data collection. Quality …

tysabri
MRI
natalizumab
  • 0 views
  • 02 Jul, 2021
  • 20 locations